Experiment summary for ENCSR594ZHO

doi:10.17989/ENCSR594ZHO

Summary

Status
released
Assay
Mint-ChIP-seq
Target
H3K4me1
Biosample summary
Homo sapiens stimulated activated naive B cell male adult (40 years) treated with 1 μg/mL anti-CD40 for 72 hours, 100 ng/mL Interleukin-4 for 72 hours, 10 μg/mL anti-IgM for 72 hours
Biosample Type
primary cell
Replication type
unreplicated
Treatments
1 μg/mL anti-CD40 for 72 hours, 100 ng/mL Interleukin-4 (UniProtKB:P05112) for 72 hours, 10 μg/mL anti-IgM for 72 hours
Nucleic acid type
DNA
Controls

Attribution

ENCODE4 project
Lab
Bradley Bernstein, Broad
Award
UM1HG009390 (Bradley Bernstein, Broad)
Project
ENCODE
External resources
Aliases
bradley-bernstein:Project Element 6940
Date released
March 28, 2022

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Antibody
Library
12Homo sapiens male adult (40 years) stimulated activated naive B primary cell treated with 1 μg/mL anti-CD40 for 72 hours, 100 ng/mL Interleukin-4 for 72 hours, 10 μg/mL anti-IgM for 72 hoursENCBS304VHMENCAB845ARKENCLB714PTW
11Homo sapiens male adult (40 years) stimulated activated naive B primary cell treated with 1 μg/mL anti-CD40 for 72 hours, 100 ng/mL Interleukin-4 for 72 hours, 10 μg/mL anti-IgM for 72 hoursENCBS304VHMENCAB845ARKENCLB078GMV